Related Experiment Video
Updated: Jun 21, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Binding Affinity Determination in Drug Design: Insights from Lock and Key, Induced Fit, Conformational Selection, and
1Drug Design and Bioinformatics Lab, Department of Chemistry, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
Predicting binding affinity, crucial for drug design, requires understanding protein-ligand interactions. Introducing ligand trapping alongside existing models offers a unified framework for accurate binding affinity determination.
Area of Science:
- Computational chemistry
- Structural biology
- Drug discovery
Background:
- Binding affinity quantifies molecule-target protein interaction strength, vital for therapeutic development.
- Existing protein-ligand recognition models (lock and key, induced fit, conformational selection) are incomplete.
- Current computational methods for predicting binding affinity yield unsatisfactory results.
Purpose of the Study:
- To explore the link between binding affinity and protein-ligand interaction models.
- To highlight the limitations of current models in explaining binding affinity.
- To introduce ligand trapping as a concept to address dissociation mechanisms.
Main Methods:
- Review of existing protein-ligand interaction models.
- Analysis of computational strategies for binding affinity prediction.
- Introduction and conceptualization of ligand trapping.
Main Results:
- Current models inadequately capture the full mechanism of binding affinity.
- Models focus on ligand binding but neglect ligand dissociation.
- Ligand trapping offers a mechanism for understanding dissociation.
Conclusions:
- A unified theoretical framework combining existing models with ligand trapping is proposed.
- This framework may enable accurate prediction of binding affinity.
- Addressing both binding and dissociation is key for improved drug design.
More Related Videos
10:58Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
Related Concept Videos
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
The Equilibrium Binding Constant and Binding Strength
Protein-Drug Binding: Determination Methods
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Drug-Receptor Bonds
In...
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...